Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026)

Arvinas (ARVN) recorded quarterly Amortizatization of Intangibles of $400000.0 in Q1 2026, down 83.33% quarter-over-quarter from $2.4 million in Q4 2025, and down 89.47% on a YoY basis from $3.8 million in Q1 2025.

Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends

Arvinas' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $400000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 89.47% year-over-year to $400000.0; the TTM figure through Mar 2026 stood at $9.4 million (down 62.55% YoY), while the FY2025 annual figure was $12.8 million, down 41.28% from the prior year.
  • Amortizatization of Intangibles was $400000.0 for Q1 2026 at Arvinas, down from $2.4 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $10.7 million in Q2 2024 to a low of -$7.2 million in Q4 2022.
  • Historically, Amortizatization of Intangibles has averaged $1.8 million across 5 years, with a median of $2.4 million in 2025.
  • Biggest YoY gain for Amortizatization of Intangibles was 2333.33% in 2022; the steepest drop was 500.0% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$7.2 million in 2022, then soared by 106.94% to $500000.0 in 2023, then jumped by 840.0% to $4.7 million in 2024, then plunged by 48.94% to $2.4 million in 2025, then sank by 83.33% to $400000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $400000.0 (Q1 2026), $2.4 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - 400,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 400,000.00
Mar 31, 2026 400,000.00
Dec 31, 2025 2.40 Mn
Dec 31, 2025 2.40 Mn
Sep 30, 2025 3.10 Mn
Sep 30, 2025 3.10 Mn
Jun 30, 2025 3.50 Mn
Jun 30, 2025 3.50 Mn
Mar 31, 2025 3.80 Mn
Mar 31, 2025 3.80 Mn
Dec 31, 2024 4.70 Mn
Dec 31, 2024 4.70 Mn
Sep 30, 2024 5.90 Mn
Sep 30, 2024 5.90 Mn
Jun 30, 2024 10.70 Mn
Jun 30, 2024 10.70 Mn
Mar 31, 2024 500,000.00
Mar 31, 2024 500,000.00
Dec 31, 2023 500,000.00
Dec 31, 2023 500,000.00